0001144204-17-065938.txt : 20171229 0001144204-17-065938.hdr.sgml : 20171229 20171229172544 ACCESSION NUMBER: 0001144204-17-065938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171208 FILED AS OF DATE: 20171229 DATE AS OF CHANGE: 20171229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreck Edward CENTRAL INDEX KEY: 0001572822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 171282741 MAIL ADDRESS: STREET 1: 700 NORTH BRAND BLVD. STREET 2: SUITE 450 CITY: GLENDALE STATE: CA ZIP: 91203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-839-5200 MAIL ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 4 1 tv481458_4.xml OWNERSHIP DOCUMENT X0306 4 2017-12-08 1 0001083446 Apollo Medical Holdings, Inc. AMEH 0001572822 Schreck Edward 700 N. BRAND BLVD. SUITE 1400 GLENDALE CA 91203 0 0 0 1 Former Director Stock Option (right to buy) 5 2016-10-14 2026-09-14 Common Stock, par value $0.001 per share 20000 140000 D Stock Option (right to buy) 5.79 2016-03-15 2026-02-14 Common Stock, par value $0.001 per share 20000 140000 D Stock Option (right to buy) 0.145 2012-02-01 2022-02-01 Common Stock, par value $0.001 per share 100000 140000 D This form is not filed to reflect any transactions but to disclose that Reporting Person resigned from the board of directors of Apollo Medical Holdings, Inc. ("ApolloMed"), effective as of the closing of a merger between Apollo Acquisition Corp., a wholly owned subsidiary of ApolloMed, and Network Medical Management, Inc., a California corporation, on December 8, 2017, and as a result, is no longer subject to Section 16, Form 4 or Form 5 obligations based on his directorship at ApolloMed. The option vested at the rate of one-twelfth of the shares per month commencing on October 14, 2016. The option vested at the rate of one-twelfth of the shares per month commencing on March 15, 2016. The option vested at the rate of one-third of the shares per year commencing on February 1, 2012. As of December 8, 2017, Reporting Person had direct ownership of stock options with respect to 140,000 shares of common stock of ApolloMed. /s/ Edward Schreck 2017-12-28